1,369
Participants
Start Date
October 21, 2022
Primary Completion Date
February 14, 2023
Study Completion Date
February 14, 2023
JT001
JT001 administered orally in tablet form every 12 hours for 5 days
Placebo
Placebo matching JT001 administered orally in tablet form every 12 hours for 5 days
Shulan (Hangzhou) Hospital, Hangzhou
Fuzhou Pulmonary Hospital Of Fujian, Fuzhou
The third people's hospital of Shenzhen, Shenzhen
Wuhan Infections Diseases Hospital, Wuhan
The Fourth Hospital in Inner Mongolia, Hohhot
The Sixth People's Hospital of ShenYang, Shenyang
Shandong Public Health Clinical Center, Jinan
Shanghai Public Health Clinical Center, Shanghai
Quzhou People's Hospital, Quzhou
Sponsor GmbH
OTHER
Shanghai Vinnerna Biosciences Co., Ltd.
INDUSTRY